Fol. Biol. 2005, 51, 82-84
https://doi.org/10.14712/fb2005051030082
The Effect of Gemcitabine in the Treatment of Rejection in Experimental Small Intestine Transplantation
References
1. 2000) Intestinal transplantation: indications, results and strategy. Curr. Opin. Clin. Nutr. Metab. 3, 329-338.
< , O., Lacaille, F., Jan, D., Ricour, C. (https://doi.org/10.1097/00075197-200009000-00002>
2. 1997) Intestinal transplantation: 1997 report of the international registry. Transplantation 67, 1061-1064.
< , D. (https://doi.org/10.1097/00007890-199904150-00021>
3. 2003) Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in rat. Transplantation 76, 1046-1052.
< , H. C., Oberladstätter, J., Schneeberger, S., Hittmair, A., Klima, G., Obrist, P., Öllinger, R., Roberts, K., Schubert, H., Steurer, W., Margreiter, R. (https://doi.org/10.1097/01.TP.0000090544.17227.57>
4. 2002) Gemcitabine in models of acute and accelerated rejection. Transpl. Proc. 34, 1420-1421.
< , F., Wilker, S., Maas, E., Berendel, M. D., Grimm, H., Korom, S. (https://doi.org/10.1016/S0041-1345(02)02911-1>
5. 1999) Gemcitabine – a novel immunosuppressive agent prevents rejection in a rat cardiac transplantation model. Transplantation 68, 1051-1053.
< , R., Fischer, M., Roberts, K., Schmidt, T., Hittmair, A., Schirmer, M., Geisen, F., Tiefenthaler, M., Konwalinka, G. (https://doi.org/10.1097/00007890-199910150-00025>
6. 1994) The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation. Transplantation 58, 690-697.
< , S. V., Farmer, D. G., Kuniyoshi, J. S., Robert, M., Khadavi, A., Shaked, A., Busuttil, R. W. (https://doi.org/10.1097/00007890-199409270-00009>
7. 2005) Gemcitabine does not prevent acute rejection of the transplanted liver in rats. Transpl. Int. 17, 687-691.
< , H., Kriz, J., Honsova, E., Kudla, M., Pantoflicek, T., Tscherentsova, E., Kocik, M., Saudek, F., Ryska, M. (https://doi.org/10.1007/s00147-004-0752-1>
8. 1971) Transplantation of small bowel in the rat: Technical and immunological considerations. Surgery 70, 693-702.
, G. J., Russell, P. S. (
9. 1989) 2’2’-difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleotides 8, 775.
, W., Gandhi, V., Chubb, S. (
10. 1995) Preclinical characteristics of gemcitabine. Anticancer Drugs 6 (Suppl. 6), 7-13.
< , W., Huang, P., Gandhi, V. (https://doi.org/10.1097/00001813-199512006-00002>
11. 1995) Indefinite survival of rat islet allografts following infusions of donor bone marow without cytoablation. Cell Transplant. 5, 53-55.
< , C., Murase, N., Rastellini, C., Behboo, R., Demetris, A. J., Starzl, T. E. (https://doi.org/10.1177/096368979600500110>